{"id":"W4313202305","doi":"10.51731/cjht.2022.531","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Drug; Adjuvant; Oncology; Internal medicine; Cancer; Pharmacology; Immunotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002964033,0.00008046446,0.0002844317,0.0004726175,0.0003967653,0.000009613187,0.0001930827,0.00004067784,0.0003304747],"category_scores_gemma":[0.00008767348,0.00007047202,0.00007808086,0.0002854348,0.00008852794,0.00004049541,0.00002325038,0.000463977,0.000006448027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009499267,"about_ca_system_score_gemma":0.005222593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006206034,"about_ca_topic_score_gemma":0.001057111,"domain_scores_codex":[0.9990362,0.0000377812,0.0003214699,0.00008994967,0.0001847857,0.0003298064],"domain_scores_gemma":[0.9994307,0.00001259881,0.0001965054,0.0001870552,0.00007016363,0.0001029362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007800342,0.00006401161,0.0257365,0.0000721192,0.0001216713,0.001065802,0.0005466595,0.00001593731,0.00003072233,0.0008157444,0.04825231,0.9232005],"study_design_scores_gemma":[0.001763067,0.003058444,0.01437078,0.00006967522,0.00003862698,0.003154582,0.006776036,0.000004048174,0.0002709176,0.002830373,0.9675561,0.0001073423],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4169654,0.3043562,0.0001994544,0.2684571,0.002487705,0.0009871019,0.0001786458,0.0003416624,0.006026773],"genre_scores_gemma":[0.9975039,0.0001796858,0.0003021258,0.001634389,0.00001243475,0.00001173053,0.00000250443,0.00001272118,0.0003405076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9230932,"threshold_uncertainty_score":0.9381709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03071242189749569,"score_gpt":0.2907010161769475,"score_spread":0.2599885942794519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}